Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial pulmonary fibrosis.

G L Snider

    Chest
    |March 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Animal models reveal that lung injuries trigger a consistent fibrotic response involving inflammatory cells. Protecting specific lung cells from injury is key to preventing and treating pulmonary fibrosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Desmosine as a biomarker of elastin degradation in COPD: current status and future directions.

    The European respiratory journal·2008
    Same author

    [American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency].

    Pneumologie (Stuttgart, Germany)·2005
    Same author

    Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema.

    The European respiratory journal·2004
    Same author

    Scanning tunneling microscopy and spectroscopy investigations of QCA molecules.

    Ultramicroscopy·2003
    Same author

    Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report.

    Respiratory medicine·2002
    Same author

    Limitations of randomized clinical trials for evaluating emerging operations: the case of lung volume reduction surgery.

    The Annals of thoracic surgery·2001
    Same journal

    A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

    Chest·2026
    Same journal

    Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

    Chest·2026
    Same journal

    Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

    Chest·2026
    Same journal

    Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

    Chest·2026
    Same journal

    Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

    Chest·2026
    Same journal

    How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

    Chest·2026
    See all related articles

    Area of Science:

    • Pulmonary Medicine
    • Cell Biology
    • Immunology

    Background:

    • Idiopathic pulmonary fibrosis (IPF) involves a complex fibrotic response in the lungs.
    • Animal models show a consistent reaction of lung tissue to various injuries.

    Purpose of the Study:

    • To elucidate the role of inflammatory and immune cells in the fibrotic process of IPF.
    • To identify key cellular targets for preventing and treating pulmonary fibrosis.

    Main Methods:

    • Utilized animal models of lung injury to study the fibrotic response.
    • Analyzed the contribution of inflammatory and immune cells to lung fibrosis.
    • Investigated the role of endothelial and epithelial cells in the fibrogenic process.

    Main Results:

    Related Experiment Videos

    • Inflammatory and immune cells significantly contribute to lung injury and fibrosis.
    • Cellular secretions influence lung cell traffic and connective tissue production.
    • Injury to endothelial and type I epithelial cells is critical for fibrosis development.

    Conclusions:

    • Understanding factors that injure lung cells is crucial for IPF treatment.
    • Developing methods to protect lung cells may prevent and treat pulmonary fibrosis.
    • Targeting cellular injury pathways offers a promising therapeutic strategy for IPF.